Could this FTSE 100 chemicals stock rally another 26% in 2024?

Shares in Croda International are finishing the year strong. But is the FTSE 100 stock set to continue its recovery into 2024?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Engineer Project Manager Talks With Scientist working on Computer

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

During the last couple of months, FTSE 100 stock Croda International (LSE:CRDA) is up 26%. But the share price is still well short of where it was at the start of 2023.

The company’s earnings have fallen sharply this year, largely due to excess inventory at its customers. But as this wears down, could the stock be set for a recovery in 2024?

Time for a recovery?

In general, 2023 hasn’t been a good year for Croda. All of the company’s operating units have struggled with the surge in demand during the pandemic falling away.

This has most notably been the case in its life sciences division, which makes lipids used in vaccines. According to Pfizer, demand for boosters has fallen from 70% in the US to around 20%.

Croda’s customers have therefore found themselves with excess inventory. As a result, sales have slowed and profits have fallen from £2.71 in 2022 to an estimated £1.65 this year.

Things aren’t likely to get back to their pandemic highs, but they probably won’t be as bad as this year again, either. So with the share price rising, is there a chance to buy the stock for a 2024 recovery?

Forecasts

Analysts don’t particularly think so. The average price target for Croda International in 2024 is around 3% higher than the current level of the stock. 

For 2024, earnings per share are expected to be £1.75, rising to £2.04 and £2.15 over the next few years. I think this is plausible, especially with sales in the company’s beauty division already starting to recover. 

The estimates represent steady progress without reaching the £2.50 and £2.71 per share levels of the pandemic. But the question for investors is whether or not the current share price implies something more.

According to the analysts at J.P. Morgan, it does. And I think they have point.

Valuation

Right now, Croda shares trade at a price-to-earnings (P/E) ratio of 36. That’s a high multiple for a FTSE 100 stock, but its earnings are unusually low at the moment. 

If the company’s earnings come in as expected over the next few years, Croda should generate £5.94 in earnings per share. That’s an 11% return at today’s prices.

The company is also fairly capital intensive. With significant equipment to maintain, only around 50% of the cash the business generates becomes free cash available to shareholders.

As a result, I think the earnings estimates imply around a 6% return after three years, which isn’t particularly high. I’d therefore be looking for much more growth beyond this to justify an investment.

Should investors consider buying Croda International shares?

I think there’s a lot to like about Croda International. The firm has a strong balance sheet and its earnings are clearly likely to grow from here after an unusually difficult demand environment.

The trouble is, the current share price seems to recognise this. As a result, analysts are doubtful of a meaningful rally into 2024 and I don’t see the stock as an obvious bargain from a long-term perspective.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

JPMorgan Chase is an advertising partner of The Ascent, a Motley Fool company. Stephen Wright has no position in any of the shares mentioned. The Motley Fool UK has recommended Croda International Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Here’s the best-performing FTSE 100 stock of the last 10 years

Private equity firm 3i has outperformed the rest of the FTSE 100 over the last 10 years. And its big…

Read more »

Fans of Warren Buffett taking his photo
Investing Articles

Here’s why Warren Buffett is selling shares (and why I’m not)

Warren Buffett cited tax considerations as his reason for selling shares in Apple. But this isn’t something most UK investors…

Read more »

Investing Articles

What on earth is going on with the AstraZeneca share price?

The AstraZeneca share price has fallen 30% from its peak in August. Dr James Fox explains what’s going on with…

Read more »

Investing Articles

2 high-yield FTSE 100 shares I’d consider buying for passive income…and one I’d avoid

Some FTSE 100 stocks have eye-popping dividend yields. But will the passive income actually be dished out? Paul Summers takes…

Read more »

Smart young brown businesswoman working from home on a laptop
Investing Articles

These 2 former stock market darlings are trying my patience! Time to sell?

Harvey Jones thought he was getting a bargain when he snapped up these too much-loved FTSE 100 dividend growth stocks.…

Read more »

Investing Articles

Here’s how I’d use £3,000 to target a second income that grows each year

Our writer explains the approach he'd take to trying to build a second income that gets bigger over time, by…

Read more »

Elevated view over city of London skyline
Investing Articles

Is it time to buy this incredible FTSE dividend share?

Christopher Ruane examines one FTSE 100 share with a phenomenal dividend history. Does a steep share price fall this year…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

This FTSE 100 share has just crashed another 20%. Its P/E is now just 9.9 so should I buy?

Harvey Jones was tempted to buy this FTSE 100 share after it crashed in October. Now it's crashed again, it…

Read more »